Gene expression profiling in cervical cancer: An exploration of intratumor heterogeneity

Clinical Cancer Research

Volumn 12, Issue 19, 2006, Pages 5632-5640

  Bachtiary, Barbara ^a,d   Boutros, Paul C ^a,b   Pintilie, Melania ^a   Shi, Willa ^a   Bastianutto, Carlo ^a   Li, Jian Hua ^a   Schwock, Joerg ^a,b,c   Zhang, Wendy ^a,b   Penn, Linda Z ^a,b   Jurisica, Igor ^a,b   Fyles, Anthony ^a   Liu, Fei Fei ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL HETEROGENEITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NUCLEIC ACID HYBRIDIZATION; PRIORITY JOURNAL; RNA EXTRACTION; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; UTERINE CERVICAL NEOPLASMS;

EID: 33750352288     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0357     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Kapp KS, Stuecklschweiger GF, Kapp DS, et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:531-40.
3. Sopov I, Sorensen T, Magbagbeolu M, et al. Detection of cancer-related gene expression profiles in severe cervical neoplasia. Int J Cancer 2004;112:33-43.
4. Cheng Q, Lau WM, Chew SH, Ho TH, Tay SK, Hui KM. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. Br J Cancer 2002;86:274-81.
5. Ahn WS, Bae SM, Lee JM, et al. Searching for pathogenic gene functions to cervical cancer. Gynecol Oncol 2004;93:41-8.
6. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005;331:269-91.
7. Wong YF, Selvanayagam ZE, Wei N, et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 2003;9:5486-92.
8. Harima Y, Togashi A, Horikoshi K, et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 2004;60:237-48.
9. Kuo WP, Jenssen TK, Butte AJ, Ohno-Machado L, Kohane IS. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 2002;18:405-12.
10. Barranco SC, Perry RR, Durm ME, et al. Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapy. Cancer Res 1994;54:5351-6.
11. Chang AR, Grignon DJ, Keeney MM, Koster JL, Kirk ME. DNA content in cervical carcinoma: a flow cytometric assessment of DNA heterogeneity. Int J Gynecol Pathol 1994;13:330-6.
12. Guo Z, Wu F, Asplund A, et al. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma. Mod Pathol 2001;14:54-61.
13. Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 2000;191:961-76.
14. Hu X, Pang T, Asplund A, Ponten J, Nister M. Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity. J Exp Med 2002;195:845-54.
15. Pang T, Hu X, Mazurenko N, Kisseljov F, Ponten J. Multiple variants of HPV16 E6 gene in cervical invasive squamous cell carcinoma. Anticancer Res 2002;22:1011-6.
16. Nguyen HN, Sevin BU, Averette HE, Ramos R, Ganjei P, Perras J. Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry. Cancer 1993;71:2543-50.
17. Lyng H, Beigi M, Svendsrud DH, et al. Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix. Int J Cancer 2004;111:358-66.
18. Hedley D, Pintilie M, Woo J, et al. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res 2003;9:5666-74.
19. Haugland HK, Vukovic V, Pintilie M, etal. Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 2002;53:854-61.
20. Wong RK, Fyles A, Milosevic M, Pintilie M, Hill RP. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. Int J Radiat Oncol Biol Phys 1997;39:405-12.
21. Lyng H, Sundfor K, Rofstad EK. Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother Oncol 1997;44:163-9.
22. Milosevic M, Fyles A, Wong R, et al. Interstitial fluid pressure in cervical carcinoma: within tumor heterogeneity, and relation to oxygen tension. Cancer 1998;82:2418-26.
23. Lyng H, Vorren AO, Sundfor K, et al. Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy. Int J Cancer 2001;96:182-90.
24. Fyles A, Milosevic M, Hedley D, et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002;20:680-7.
25. Milosevic M, Fyles A, Hedley D, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001;61:6400-5.
26. Wu Z, Irizarry RA, Gentleman R, Murillo FM, Spencer FA. A model based background adjustment for oligonucleotide expression arrays. Baltimore (MD): Technical Report, John Hopkins University, Department of Biostatistics Working Papers; 2003.
27. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
28. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15.
29. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
30. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein encoding transcriptomes. Proc Natl Acad Sci U S A 2004;101:6062-7.
31. Zeeberg BR, Feng W, Wang G, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003;4:R28.
32. Weiner EA, Steward BJ. Assessing individuals: psychological and educational tests and measurements. Boston: Little Brown; 1984.
33. Streiner DL, Norman GR. Reliability. Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press; 1989.
34. Van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
35. Breitburd F, Ramoz N, Salmon J, Orth G. HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 1996;7:359-71.
36. Affymetrix.com [homepage on the internet]. Latin Square Data for Expression Algorithm Assessment. Available from: http://www.affymetrix.com/ support/technical/sample_data/datasets.affx.
37. van't Veer LJ, Dai H, Van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:484-5.
38. Trautmann K, Steudel C, Grossmann D, et al. Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability. World J Gastroenterol 2005;11:5993-6.
39. Blackhall FH, Pintilie M, Wigle DA, et al. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia 2004;6:761-7.
40. O'Sullivan M, Budhraja V, Sadovsky Y, Pfeifer JD. Tumor heterogeneity affects the precision of microarray analysis. Diagn Mol Pathol 2005;14:65-71.